This section presents pharmaceutical projects that are announced from time-to-time around the world.
CordenPharma is investing US$981 million 900 million to expand its peptide platform at its sites in USA, and Europe The expansions, which encompass both enhancements to existing facilities
LOTTE Biologics is investing US$35 billion 46 trillion to construct a new Bio Campus in Songdo, Incheon, Korea This stateoftheart facility, covering an impressive
Vetter intends to relocate and expand its development services site from Skokie to Des Plaines, Illinois, bolstering its US presence The project also includes investments in commercial operations
SGS North America has expanded its capacity and capabilities to enhance biologics testing services in the USA The 60,000 squarefoot, stateoftheart facility in Lincolnshire
Bora Pharmaceuticals plans for the expansion of sterile manufacturing facility in Maryland, USA to provide Sterile FillFinish Services The newly acquired 87,000
Novo Nordisk plans to invest U$41 billion towards constructing a second fill and finish manufacturing facility in the USA The expansion project will increase production capacity significantly
LFB Biomanufacturing is planning a capacity expansion of its industrial site in France, Europe The expansion will not only boost production capabilities
Thermo Fisher Scientific is investing $58 million to expand its GMP lab in Wisconsin, USA This new stateoftheart facility spans 72,500 square feet and includes a clinical research laboratory building
Sanofi is investing US$375 million 35 million to open new bioproduction capacity at its facilities in VitrysurSeine Val dae Marne, Loe Trait SeineMaritime, and Lyon Gerland Rhne in France
Kyowa Kirin invests US$530 million to construct a stateoftheart manufacturing facility in North Carolina, USA The 171,700squarefoot, tworeactor facility will accelerate the development
